Director, Pharmaceutical Stability

Not Interested
Bookmark
Report This Job

profile Job Location:

San Diego, CA - USA

profile Monthly Salary: Not Disclosed
Posted on: 20 days ago
Vacancies: 1 Vacancy

Job Summary

About Acadia Pharmaceuticals
Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinsons disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimers disease psychosis and Lewy body dementia psychosis along with earlier-stage programs that address other underserved patient needs. At Acadia were here to be their difference.

Please note that this position is based in San Diego CA or Princeton NJ. Acadias hybrid model requires this role to work in our office three days per week on average.

The Director Pharmaceutical Stability leads and oversees outsourced stability testing activities across Acadias drug development portfolio from early development through commercialization. The position is responsible for managing multiple contract service providers (CSPs) ensuring delivery of highquality consistent and cGMPcompliant stability studies. Key responsibilities include negotiating and overseeing vendor agreements reviewing and approving stability protocols and reports and driving alignment with global regulatory expectations. The role also plays a critical part in evolving Acadias stability policies and serves as the Analytical Development subject matter expert (SME) for regulatory submissions stability trending and OOS/OOT investigations.

Primary Responsibilities:

  • Continue to develop and revise Acadia policies related to performing stability testing throughout the drug development stages
  • Develops stability protocol for intermediates APIs and drug products:
    • Draft review and/or approves stability protocols
    • Draft review and/or approves stability related chemistry manufacturing and control (CMC) sections of regulatory documentation (such as 3.2.P.8 and 3.2.S7).
  • Provides oversight of testing at CSPs:
    • Negotiate and/or review and approve stability related agreements.
    • Actively monitors stability programs at CSPs
    • Reviews stability data for trends out-of-specification (OOS) and out-of-trend (OOT) results
    • Reports delays in receiving stability data from CSP to management
  • Business Owner of Acadia implemented stability software
    • Such as SLIM and SLIM Stat
  • Liaises with pharmaceutical development manufacturing quality and regulatory counterparts to develop stability protocols for regulatory submissions
  • Draft review and/or approve stability reports supporting shelf-life expiry and retest period
  • Provide trending of stability data
  • Meet with project teams to identify drug substance intermediates and drug product batches required to be added to stability programs
  • Manage the activities of FTEs and/or consultants assigned to the Stability Group
  • Develop FTEs to grow within Acadia
  • Oversee laboratory investigations related to stability studies:
    • Investigates and/or review CSP OOS/OOT stability investigations
    • Assesses performance of CSP laboratory for accuracy and technical expertise

Education/Experience/Skills:

  • BS in Chemistry or related field. A minimum of 20 years progressively responsible experience with a focus on drug substance and drug product stability studies supervise analytical testing and stability protocols/reports. A combination of relevant education and applicable job experience may be considered.

Must possess:

  • Experience with oversight management of CSP analytical laboratory and writing stability sections for regulatory submissions
  • Good understanding of GMP working environments and regulatory guidance and regulations (e.g. ICH guidance 21 CFR Part 211 21 CFR Part 11)
  • Working knowledge of United States Pharmacopeia (USP) and European Pharmacopeia (EP) and FDA/ICH/WHO stability related guidance
  • Strong negotiating skills.
  • Excellent organizational and documentation skills
  • Experience authoring technical stability reports and CMC sections for regulatory filings
  • Ability to manage change in a dynamic environment
  • Skilled at effectively communicating (verbally and written) department or area issues and results within and across functional areas and conducting presentations of technical information concerning specific projects or timelines. Able to gain cooperation of others
  • Skilled at effectively leading a cooperative team effort and organizing resources to achieve team goals. Able to make and prioritize process and resource decisions based on overall team needs
  • Ability to travel 20% of time both domestically and internationally

Scope:

Provides guidance to subordinates and/or manages department section to achieve goals in accordance with established policies and to meet schedules and/or resolve problems. Receives assignments in the form of objectives. Follows processes and operational policies in selecting methods and techniques for obtaining solutions; determines how to use resources to meet schedules and goals. Works on issues of diverse scope which require evaluation of a variety of factors ad an understanding of functional area objectives and trends. Erroneous decisions or failure to achieve results may add to costs and impact the short-term goals of the organization.

Physical Requirements:

While performing the duties of this job the employee is regularly required to stand; walk; sit; use hands to finger handle or feel; reach with hands and arms; climb or balance; stoop kneel crouch see talk or hear in a standard office environment and independently from remote locations. Employee must occasionally lift and/or move up to 20 pounds. Ability to travel by car or airplane independently up to 20% of the time and work after hours if required by travel schedule or business issues

#LI-HYBRID #LI-SM1


Required Experience:

Director

About Acadia PharmaceuticalsAcadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinsons d...
View more view more

About Company

Company Logo

For 30 years, Acadia has been working at the forefront of healthcare to protect what makes you, uniquely you. This is our purpose.

View Profile View Profile